Page last updated: 2024-10-25

ciglitazone and Leukemia, Basophilic, Acute

ciglitazone has been researched along with Leukemia, Basophilic, Acute in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Leukemia, Basophilic, Acute: A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lenman, A1
Fowler, CJ1

Other Studies

1 other study available for ciglitazone and Leukemia, Basophilic, Acute

ArticleYear
Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system.
    British journal of pharmacology, 2007, Volume: 151, Issue:8

    Topics: Amidohydrolases; Animals; Anti-Inflammatory Agents; Brain; Brain Neoplasms; Cannabinoid Receptor Mod

2007